Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Dr. Lilge OSA Webinar - Aug. 18
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(298)
•••
Comment by fredgoodwinsonon Jun 16, 2021 10:00am
183 Views
Post# 33394744

RE:RE:RE:RE:RE:RE:Dr. Lilge OSA Webinar - Aug. 18

RE:RE:RE:RE:RE:RE:Dr. Lilge OSA Webinar - Aug. 18 This may sound like a cop-out Rumpl -`cos it is - but have been here all these years`for the cancer and the covid thing came from completely out of left field so more than anything have hoped that it did not serve as a distraction.

Part of this is down to how our brilliant cancer tech has not even been acknowledged never mind backed by the Canadian Health Establishment over the last 7 years`and knowing how much it takes to bring a vaccine into use just hoped we weren`t to be distracted with a red herring.

Would be the first to be delighted if the Govnt.has changed its`ways but as of yet no direct evidence that we will be carried either on Cancer or Covid. The new lab set-up is encouraging though.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities